Last 699.75 INR
Change Today +2.80 / 0.40%
Volume 43.4K
TRP On Other Exchanges
Symbol
Exchange
Natl India
As of 7:06 AM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

torrent pharmaceuticals ltd (TRP) Snapshot

Open
698.95
Previous Close
696.95
Day High
701.90
Day Low
692.00
52 Week High
07/15/14 - 739.00
52 Week Low
08/22/13 - 384.90
Market Cap
118.4B
Average Volume 10 Days
95.8K
EPS TTM
39.23
Shares Outstanding
169.2M
EX-Date
06/16/14
P/E TM
17.8x
Dividend
10.00
Dividend Yield
1.43%
Current Stock Chart for TORRENT PHARMACEUTICALS LTD (TRP)

Related News

No related news articles were found.

torrent pharmaceuticals ltd (TRP) Related Businessweek News

No Related Businessweek News Found

torrent pharmaceuticals ltd (TRP) Details

Torrent Pharmaceuticals Limited, together with its subsidiaries, manufactures and sells branded and unbranded generic pharmaceutical products in India and internationally. The company offers its products in therapeutic areas of cardiovascular, central nervous system, gastrointestinal, anti-infective, diabetology, and pain management areas. It offers products in the form of tablets, capsules, and parenterals. The company’s active pharmaceutical ingredients comprise nicorandil, risperidone, venlafaxine hydrochloride, ropinarole hydrochloride, duloxetine hydrochloride, ormeloxifen hydrochloride, nebivolol hydrochloride, lamotrigine, sertraline hydrochloride, and clopidogrel bisulphate, as well as atomoxatine hydrochloride, rivastigmine hydrogen tartrate, and esomeprazole sodium. It also provides contract manufacturing services primarily for human insulin. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. Torrent Pharmaceuticals Limited was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Private Limited.

9,540 Employees
Last Reported Date: 07/2/14
Founded in 1959

torrent pharmaceuticals ltd (TRP) Top Compensated Officers

Executive Vice Chairman, Managing Director, M...
Total Annual Compensation: 313.0K
Director of Research & Development, Whole-Tim...
Total Annual Compensation: 27.4M
Compensation as of Fiscal Year 2014.

torrent pharmaceuticals ltd (TRP) Key Developments

Torrent Pharmaceuticals Ltd. Reports Audited Standalone and Unaudited Consolidated Earnings Results for the Fourth Quarter Ended March 31, 2014; Reports Audited Standalone and Consolidated Earnings Results Year Ended March 31, 2014

Torrent Pharmaceuticals Ltd. reported audited standalone and consolidated earnings results for the fourth quarter and year ended March 31, 2014. For the quarter, on standalone basis, the company’s net sales /income from operations were INR 9,370 million compared to INR 7,030 million a year ago. Profit from operations before other income finance cost and exceptional items was INR 3,180 million compared to INR 2,290 million a year ago. Profit from ordinary activities before tax was INR 3,080 million against INR 1,970 million a year ago. Net profit was INR 2,520 million or INR 14.89 per basic and diluted share compared to INR 1,530 million or INR 9.04 per basic and diluted share a year ago. Net income from operations was INR 9,540 million compared to INR 7,700 million a year ago. For the year, on standalone basis, the company’s net sales /income from operations were INR 32,210 million compared to INR 26,180 million a year ago. Profit from operations before other income finance cost and exceptional items was INR 9,800 million compared to INR 6,070 million a year ago. Profit from ordinary activities before tax was INR 9,580 million against INR 6,650 million a year ago. Net profit was INR 7,620 million or INR 45.05 per basic and diluted share compared to INR 5,460 million or INR 32.29 per basic and diluted share a year ago. Net income from operations was INR 33,650 million compared to INR 27,670 million a year ago. For the quarter, on consolidated basis, the company’s net sales /income from operations were INR 12,070 million compared to INR 8,030 million a year ago. Profit from operations before other income finance cost and exceptional items was INR 3,270 million compared to INR 1,980 million a year ago. Profit from ordinary activities before tax was INR 3,170 million against INR 1,590 million a year ago. Net profit was INR 2,440 million or INR 14.44 per basic and diluted share compared to net profit of INR 1,111 million or INR 6.59 per basic and diluted share a year ago. EBITDA was INR 3,500 million compared to INR 2,200 million a year ago. For the year, on consolidated basis, the company’s net sales /income from operations were INR 40,360 million compared to INR 30,540 million a year ago. Profit from operations before other income finance cost and exceptional items was INR 8,650 million compared to INR 6,100 million a year ago. Profit from ordinary activities before tax was INR 8,440 million against INR 5,820 million a year ago. Net profit was INR 6,640 million or INR 39.23 per basic and diluted share compared to net profit of INR 4,350 million or INR 25.58 per basic and diluted share a year ago. EBITDA was INR 9,520 million compared to INR 6,930 million a year ago.

Torrent Pharmaceuticals Limited Recommends Final Dividend Payable on or Around August 04, 2014

Torrent Pharmaceuticals Limited announced that the Board of Directors at their meeting has recommended a final dividend of INR 5 per equity share of INR 5 each fully paid up further to the interim dividend of INR 5 per equity share paid during the last quarter. These final dividend amounts, if declared by the Shareholders, are proposed to be paid/dispatched on or around August 04, 2014.

Torrent Pharmaceuticals Ltd. to Report Fiscal Year 2014 Results on May 09, 2014

Torrent Pharmaceuticals Ltd. announced that they will report fiscal year 2014 results on May 09, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TRP:IN 699.75 INR +2.80

TRP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Divi's Laboratories Ltd 1,479 INR +0.65
Ipca Laboratories Ltd 837.85 INR -11.70
Jubilant Life Sciences Ltd 193.45 INR -1.20
Piramal Enterprises Ltd 632.80 INR +1.75
Wockhardt Ltd 643.85 INR +1.15
View Industry Companies
 

Industry Analysis

TRP

Industry Average

Valuation TRP Industry Range
Price/Earnings 17.7x
Price/Sales 2.8x
Price/Book 6.2x
Price/Cash Flow 15.7x
TEV/Sales 2.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TORRENT PHARMACEUTICALS LTD, please visit www.torrentpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.